Statement of Comprehensive Income
Comprehensive income is the change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owners sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
GlaxoSmithKline PLC, consolidated statement of comprehensive income
US$ in millions, translated from GBP £
Based on: 20-F (reporting date: 2014-12-31), 20-F (reporting date: 2013-12-31), 20-F (reporting date: 2012-12-31), 20-F (reporting date: 2011-12-31), 20-F (reporting date: 2010-12-31).
Comprehensive income item | Description | The company |
---|---|---|
Profit attributable to shareholders | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | GlaxoSmithKline PLC profit attributable to shareholders increased from 2012 to 2013 but then decreased significantly from 2013 to 2014. |
Comprehensive income for the year attributable to shareholders | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Exclude changes in equity resulting from investments by owners and distributions to owners. | GlaxoSmithKline PLC comprehensive income for the year attributable to shareholders increased from 2012 to 2013 but then decreased significantly from 2013 to 2014. |